Galapagos reported EUR130.64M in Gross Profit on Sales for its fiscal quarter ending in September of 2023.

Gross Profit On Sales Change Date
AstraZeneca USD 9.43B 15M Sep/2023
Gilead Sciences USD 5.5B 18M Dec/2023
Hikma Pharmaceutical USD 733M 91M Jun/2023
Roche Holding CHF 22.16B 123M Jun/2023
UCB EUR 1.79B 24M Jun/2023